International Institute of Molecular and Cell Biology, Warsaw: New Member of ScanBalt
The main goals of IIMCB are: to carry out high-quality research in molecular biomedicine, to create the best possible conditions for ambitious, motivated group leaders and their staff, to implement modern biotechnology, as well as to teach and popularize molecular biology and medicine.
Research topics at IIMCB cover the wide area of structural biology, bioinformatics, computer modeling, molecular and cell biology, neurobiology, cancer biology, and developmental genomics (zebrafish model).
The Institute is equipped with state-of-the-art technology and has excellent core facilities and supportive administration, including Scientific Coordination Unit and Grants Office. IIMCB actively collaborates with pharmaceutical and biotechnology companies such as Adamed, OncoArendi, A&A Biotechnology to develop new therapies in neurology, oncology and biotechnological products.
The Institute’s Technology Transfer Unit Biotech-IP supported scientists in their work on applicable R&D projects and IP protection. BioTech-IP evolved gradually, and a need arose to transfer the most advanced projects to an external entity, thus allowing further development in the economic environment. Patent applications and patents were transferred to Biotech Innovations Ltd which is funded by IIMCB. It is committed to turning scientific progress into marketable products and technologies and returning income to the inventors and IIMCB to support further research.
4 June 2020
First BIC Webinar is now available online!